Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Edward Dempsey

Concepts (333)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neprilysin
6
2017
47
2.400
Why?
Muscle, Smooth, Vascular
22
2017
409
2.310
Why?
Pulmonary Artery
26
2020
1024
1.820
Why?
Protein Kinase C
15
2007
271
1.800
Why?
Hypoxia
18
2021
956
1.340
Why?
rho GTP-Binding Proteins
2
2020
61
1.220
Why?
Pulmonary Circulation
7
2009
407
0.970
Why?
Isoenzymes
9
2007
283
0.730
Why?
Hypertension, Pulmonary
12
2021
1736
0.720
Why?
Lung
11
2021
3521
0.700
Why?
Evans Blue
1
2018
6
0.620
Why?
Capillary Permeability
1
2018
137
0.590
Why?
Cell Division
25
2009
754
0.570
Why?
Protein Kinase C-epsilon
3
2005
27
0.560
Why?
Myocytes, Smooth Muscle
2
2019
236
0.540
Why?
Muscle Proteins
1
2017
210
0.520
Why?
Blood Vessels
3
2016
179
0.500
Why?
Endothelium, Vascular
2
2020
830
0.440
Why?
Aging
4
2020
1611
0.440
Why?
Animals
44
2021
31565
0.430
Why?
Mice, Knockout
6
2017
2562
0.430
Why?
Receptor, Platelet-Derived Growth Factor beta
1
2013
25
0.420
Why?
Animals, Newborn
10
2007
777
0.380
Why?
Airway Remodeling
1
2010
57
0.350
Why?
Pulmonary Disease, Chronic Obstructive
3
2017
907
0.340
Why?
Cattle
16
2002
918
0.300
Why?
Mice
14
2018
14843
0.290
Why?
Fibroblasts
7
2019
834
0.290
Why?
Endothelin-1
2
2017
168
0.240
Why?
Signal Transduction
7
2020
4501
0.240
Why?
Protein Kinases
1
2007
304
0.240
Why?
Lung Neoplasms
11
2012
2159
0.240
Why?
Enzyme Activation
5
2017
771
0.220
Why?
rho-Associated Kinases
2
2019
80
0.220
Why?
Cells, Cultured
12
2017
3861
0.210
Why?
Lung Diseases
2
2007
690
0.210
Why?
Mice, Inbred C57BL
5
2017
4680
0.210
Why?
Vascular Remodeling
2
2021
153
0.210
Why?
Insulin-Like Growth Factor I
3
1997
286
0.210
Why?
Potassium Channels, Voltage-Gated
1
2002
48
0.200
Why?
Vascular Endothelial Growth Factor Receptor-2
3
2012
86
0.200
Why?
Cell Movement
3
2017
863
0.190
Why?
Vasoconstriction
1
2002
177
0.190
Why?
Growth Substances
4
1997
138
0.190
Why?
Tetradecanoylphorbol Acetate
5
1997
151
0.180
Why?
Butyrates
1
2021
53
0.180
Why?
Proto-Oncogene Proteins c-myc
2
2020
116
0.180
Why?
Phenotype
5
2017
2784
0.180
Why?
Metabolic Diseases
1
2021
98
0.180
Why?
Mitogens
2
1997
58
0.170
Why?
Forkhead Box Protein O3
1
2020
13
0.170
Why?
Receptors, G-Protein-Coupled
1
2021
186
0.170
Why?
Platelet-Derived Growth Factor
3
1997
80
0.170
Why?
Vasa Vasorum
1
2020
33
0.170
Why?
JNK Mitogen-Activated Protein Kinases
1
2020
145
0.160
Why?
rhoA GTP-Binding Protein
1
2019
72
0.160
Why?
Genotype
2
2017
1757
0.160
Why?
Cellular Microenvironment
1
2019
77
0.160
Why?
Metabolome
1
2021
274
0.160
Why?
Pulmonary Alveoli
2
2012
372
0.150
Why?
Thymidine
5
1996
58
0.150
Why?
ets-Domain Protein Elk-1
1
2017
13
0.150
Why?
Smooth Muscle Myosins
1
2017
7
0.150
Why?
Kruppel-Like Transcription Factors
1
2017
61
0.140
Why?
Actins
3
2017
376
0.140
Why?
Microfilament Proteins
1
2017
125
0.140
Why?
Vascular Diseases
1
2019
233
0.130
Why?
Chronic Disease
6
2009
1577
0.130
Why?
Calcium-Binding Proteins
1
2017
205
0.130
Why?
Substance P
1
2016
44
0.130
Why?
Doxycycline
1
2016
54
0.130
Why?
Pneumonia
1
2021
563
0.130
Why?
Duodenum
1
2016
62
0.130
Why?
Neovascularization, Pathologic
5
2020
280
0.130
Why?
Sleep Apnea Syndromes
2
2013
74
0.120
Why?
Humans
30
2021
114045
0.120
Why?
Uterus
3
2006
191
0.120
Why?
Carcinogens
2
2012
102
0.120
Why?
Myocardium
1
2019
911
0.120
Why?
In Vitro Techniques
5
2007
1003
0.120
Why?
Cell Communication
1
1996
277
0.110
Why?
Sputum
3
2005
286
0.110
Why?
Endothelial Cells
3
2021
677
0.110
Why?
Estradiol
2
1997
450
0.110
Why?
Enzyme Inhibitors
4
2002
743
0.110
Why?
Cell Proliferation
2
2017
2173
0.100
Why?
Gene Expression Regulation, Developmental
1
1997
801
0.100
Why?
Piperidines
2
2012
159
0.100
Why?
Blotting, Western
3
2012
1143
0.100
Why?
Quinazolines
2
2012
240
0.100
Why?
Gene Expression Regulation
3
2016
2322
0.100
Why?
Bronchoscopy
5
2009
196
0.090
Why?
Mice, Transgenic
1
2016
1947
0.090
Why?
Gene Expression Regulation, Enzymologic
2
2005
270
0.090
Why?
DNA Primers
2
2009
508
0.090
Why?
Somatomedins
1
1990
28
0.090
Why?
Cardiovascular Diseases
1
2021
1726
0.090
Why?
Arteries
2
2006
246
0.090
Why?
Carcinoma in Situ
3
2005
44
0.090
Why?
Precancerous Conditions
3
2004
155
0.090
Why?
Biomarkers
1
2020
3397
0.080
Why?
Maleimides
3
2000
23
0.080
Why?
Blood Pressure
3
2021
1531
0.080
Why?
Isotretinoin
1
2009
22
0.080
Why?
Tocopherols
1
2009
22
0.080
Why?
ErbB Receptors
1
2012
554
0.080
Why?
Cell Hypoxia
3
1999
221
0.080
Why?
Biomarkers, Tumor
3
2012
1032
0.080
Why?
Female
17
2012
59324
0.080
Why?
Carcinoma, Squamous Cell
2
2005
577
0.070
Why?
Male
10
2018
55396
0.070
Why?
Indoles
3
2000
300
0.070
Why?
Bronchi
2
2000
223
0.070
Why?
Galectin 1
1
2006
2
0.070
Why?
Heart Failure
1
2019
1958
0.070
Why?
Genes, ras
2
1997
91
0.070
Why?
Hyperoxia
1
2007
99
0.070
Why?
Videotape Recording
1
2006
30
0.070
Why?
Rats, Sprague-Dawley
3
2021
2182
0.060
Why?
Disease Models, Animal
2
2013
3498
0.060
Why?
Thiazolidinediones
1
2006
142
0.060
Why?
Smoking
4
2009
1382
0.060
Why?
Rats
4
2021
4913
0.060
Why?
DNA
4
1997
1350
0.060
Why?
Hypertrophy, Right Ventricular
2
2021
141
0.060
Why?
Nitric Oxide Synthase Type II
1
2005
157
0.060
Why?
Blood
2
1995
94
0.060
Why?
Calcium
2
2002
1089
0.060
Why?
Nitric Oxide Synthase Type III
1
2005
181
0.060
Why?
Endothelins
2
1996
61
0.060
Why?
Drug Synergism
3
1996
315
0.060
Why?
Drug Delivery Systems
1
2007
295
0.060
Why?
Hemodynamics
1
2009
1015
0.060
Why?
Bronchoalveolar Lavage Fluid
2
1997
580
0.060
Why?
Guinea Pigs
3
2006
136
0.060
Why?
Case-Control Studies
1
2010
3003
0.050
Why?
Fetus
2
1997
698
0.050
Why?
Stem Cells
1
2007
541
0.050
Why?
Intracellular Signaling Peptides and Proteins
1
2005
388
0.050
Why?
Shaw Potassium Channels
1
2002
4
0.050
Why?
Potassium Chloride
1
2002
32
0.050
Why?
Potassium Channel Blockers
1
2002
29
0.050
Why?
Angiotensin II
1
2002
87
0.050
Why?
Potassium Channels
1
2002
121
0.050
Why?
Nitric Oxide Synthase
1
2002
209
0.050
Why?
Antineoplastic Agents
2
2010
1875
0.050
Why?
Patient Education as Topic
1
2006
666
0.050
Why?
Tunica Media
2
1998
35
0.050
Why?
Urethane
2
2012
41
0.050
Why?
Protein Kinase C beta
2
2000
24
0.050
Why?
Macrophages
2
2021
1259
0.050
Why?
Aged
6
2010
18969
0.050
Why?
Gene Deletion
1
2002
356
0.050
Why?
Systole
1
2021
176
0.050
Why?
Fluorescence
1
2001
148
0.050
Why?
Tight Junctions
1
2021
68
0.050
Why?
Microvessels
1
2021
66
0.050
Why?
Acetylation
1
2021
209
0.050
Why?
Genetic Predisposition to Disease
1
2009
2090
0.040
Why?
Nitric Oxide
1
2005
817
0.040
Why?
Receptors, Purinergic P2Y
1
2020
7
0.040
Why?
Cytokines
2
2021
1824
0.040
Why?
Ligands
1
2021
556
0.040
Why?
Neoplasms
1
2013
2086
0.040
Why?
GTPase-Activating Proteins
1
2019
72
0.040
Why?
Trans-Activators
1
2001
366
0.040
Why?
Guanine Nucleotide Exchange Factors
1
2019
55
0.040
Why?
Light
1
2001
336
0.040
Why?
Up-Regulation
1
2021
802
0.040
Why?
Oxygen
1
2002
851
0.040
Why?
Leukocytes
1
2019
272
0.040
Why?
Immune System
1
2019
171
0.040
Why?
Phosphatidylinositol 3-Kinases
1
2020
328
0.040
Why?
Middle Aged
5
2010
26605
0.040
Why?
Proto-Oncogene Proteins c-akt
1
2020
397
0.040
Why?
Adenosine Triphosphate
1
2020
428
0.040
Why?
Aorta
2
2001
388
0.040
Why?
Disease Susceptibility
1
2019
316
0.040
Why?
Culture Media, Serum-Free
1
1997
42
0.040
Why?
Proto-Oncogene Proteins c-sis
1
1997
33
0.040
Why?
Ischemia
1
2000
361
0.040
Why?
TOR Serine-Threonine Kinases
1
2020
359
0.030
Why?
Protein Kinase C-alpha
1
1997
41
0.030
Why?
Nuclear Proteins
1
2001
591
0.030
Why?
Sensitivity and Specificity
2
2001
1690
0.030
Why?
Organ Specificity
1
1997
266
0.030
Why?
Pregnancy, Animal
1
1997
52
0.030
Why?
Reactive Oxygen Species
1
2019
522
0.030
Why?
Muscle Development
1
1997
99
0.030
Why?
Bronchial Neoplasms
1
1996
13
0.030
Why?
Microcirculation
2
2007
133
0.030
Why?
Heart Ventricles
1
2021
723
0.030
Why?
Species Specificity
1
1997
541
0.030
Why?
Rabbits
1
1997
733
0.030
Why?
Point Mutation
1
1997
216
0.030
Why?
Blood Physiological Phenomena
1
1996
13
0.030
Why?
Dose-Response Relationship, Drug
2
2010
1836
0.030
Why?
Tritium
1
1996
66
0.030
Why?
Receptors, Platelet-Derived Growth Factor
1
1996
13
0.030
Why?
Neoplasms, Second Primary
1
1997
92
0.030
Why?
Exercise
1
2006
1642
0.030
Why?
Rats, Inbred Strains
1
1996
360
0.030
Why?
Myocytes, Cardiac
1
2019
449
0.030
Why?
Young Adult
1
2010
10444
0.030
Why?
DNA Mutational Analysis
1
1996
373
0.030
Why?
Quality of Life
1
2006
2343
0.030
Why?
Protein Precursors
1
1996
119
0.030
Why?
Clinical Trials as Topic
1
2019
926
0.030
Why?
Models, Biological
1
2021
1611
0.030
Why?
Catalysis
1
1995
289
0.030
Why?
Subcellular Fractions
1
1994
77
0.030
Why?
Flow Cytometry
2
1996
1075
0.030
Why?
Adenosine Diphosphate
1
1994
76
0.030
Why?
Recombinant Proteins
1
1997
1228
0.030
Why?
Stress, Mechanical
1
1996
445
0.030
Why?
Blood Proteins
1
1996
222
0.030
Why?
Poly I-C
1
1994
51
0.030
Why?
Risk Factors
5
2009
8614
0.030
Why?
Endothelin Receptor Antagonists
1
1993
58
0.030
Why?
Hyperplasia
2
2006
163
0.030
Why?
Neoplasm Proteins
1
1996
385
0.030
Why?
Receptors, Estrogen
1
1996
371
0.030
Why?
Extracellular Matrix
2
2006
436
0.030
Why?
Complement Factor B
1
1994
100
0.030
Why?
Serotonin
1
1994
292
0.030
Why?
Methylcholanthrene
1
2012
18
0.030
Why?
Adolescent
1
2010
17800
0.030
Why?
Pregnancy
3
2006
5499
0.030
Why?
Butylated Hydroxytoluene
1
2012
31
0.030
Why?
Time Factors
2
2007
6077
0.020
Why?
Immunoenzyme Techniques
1
2012
192
0.020
Why?
Peptides, Cyclic
1
1993
252
0.020
Why?
Infant, Newborn
2
2007
5038
0.020
Why?
Blood Platelets
1
1994
326
0.020
Why?
Apoptosis
1
2000
2349
0.020
Why?
Cell Count
2
2006
303
0.020
Why?
Phorbol 12,13-Dibutyrate
1
1991
8
0.020
Why?
Aerobiosis
1
1991
20
0.020
Why?
Anaerobiosis
1
1991
48
0.020
Why?
Dimethyl Sulfoxide
1
1991
42
0.020
Why?
Epithelial-Mesenchymal Transition
1
2012
167
0.020
Why?
Tumor Cells, Cultured
3
1996
845
0.020
Why?
Protein Binding
1
1996
1888
0.020
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
225
0.020
Why?
Chemoprevention
1
2010
87
0.020
Why?
Biopsy
2
2005
1024
0.020
Why?
DNA Replication
1
1991
202
0.020
Why?
Antioxidants
1
2012
529
0.020
Why?
RNA, Messenger
1
1996
2550
0.020
Why?
Down-Regulation
1
1990
594
0.020
Why?
Molecular Targeted Therapy
1
2010
347
0.020
Why?
Kinetics
1
1991
1547
0.020
Why?
Leukocyte Common Antigens
1
2007
75
0.020
Why?
Rats, Inbred WKY
1
2006
32
0.020
Why?
Elastin
1
2006
78
0.020
Why?
Proto-Oncogene Proteins c-kit
1
2006
63
0.020
Why?
Codon
2
1997
85
0.020
Why?
Aged, 80 and over
2
2009
6306
0.020
Why?
Serum
1
2006
57
0.020
Why?
PPAR gamma
1
2006
182
0.020
Why?
Vascular Resistance
1
2006
340
0.020
Why?
Chi-Square Distribution
1
2006
492
0.010
Why?
Protein Kinase Inhibitors
1
2010
784
0.010
Why?
Collagen
1
2006
414
0.010
Why?
Adenocarcinoma
1
2010
787
0.010
Why?
Antibodies, Monoclonal
1
2010
1257
0.010
Why?
Sheep
1
2006
761
0.010
Why?
Neoplasm Recurrence, Local
1
2009
850
0.010
Why?
Teaching
1
2006
209
0.010
Why?
Polymerase Chain Reaction
2
1997
990
0.010
Why?
Neoplasm Invasiveness
1
2005
438
0.010
Why?
Epithelial Cells
2
2001
946
0.010
Why?
Vital Capacity
1
2004
254
0.010
Why?
Confidence Intervals
1
2004
302
0.010
Why?
Activities of Daily Living
1
2006
348
0.010
Why?
Gestational Age
1
2006
761
0.010
Why?
Bronchopulmonary Dysplasia
1
2007
333
0.010
Why?
Forced Expiratory Volume
1
2004
471
0.010
Why?
Base Sequence
1
2006
2114
0.010
Why?
Patient Compliance
1
2006
524
0.010
Why?
CREB-Binding Protein
1
2001
27
0.010
Why?
Metaplasia
1
2001
54
0.010
Why?
Adaptation, Psychological
1
2006
545
0.010
Why?
Single-Blind Method
1
2001
259
0.010
Why?
Fluorescent Antibody Technique
1
2001
396
0.010
Why?
Chromosomes, Human, Pair 3
1
2000
49
0.010
Why?
Loss of Heterozygosity
1
2000
40
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
57
0.010
Why?
Fibrosis
1
2002
452
0.010
Why?
Carcinoma
1
2001
198
0.010
Why?
Ki-67 Antigen
1
2000
102
0.010
Why?
Airway Obstruction
1
2001
160
0.010
Why?
Prevalence
1
2005
2247
0.010
Why?
Risk
1
2001
810
0.010
Why?
Carcinoma, Non-Small-Cell Lung
2
1997
959
0.010
Why?
Cell Death
1
2000
322
0.010
Why?
Mitotic Index
1
1997
26
0.010
Why?
Bromodeoxyuridine
1
1997
72
0.010
Why?
Mammals
1
1999
241
0.010
Why?
Cytoskeletal Proteins
1
1997
145
0.010
Why?
Tunica Intima
1
1997
78
0.010
Why?
Myosins
1
1997
125
0.010
Why?
Comorbidity
1
2001
1447
0.010
Why?
Chromosome Banding
1
1996
21
0.010
Why?
Ovariectomy
1
1997
116
0.010
Why?
Ploidies
1
1996
17
0.010
Why?
Karyotyping
1
1996
100
0.010
Why?
Ligases
1
1996
30
0.010
Why?
Tumor Suppressor Protein p53
1
2000
445
0.010
Why?
Heparin
1
1997
225
0.010
Why?
Bronchoalveolar Lavage
1
1996
82
0.010
Why?
Immunohistochemistry
1
2000
1624
0.010
Why?
Transcription, Genetic
1
2001
1310
0.010
Why?
Immunophenotyping
1
1996
274
0.010
Why?
Regional Blood Flow
1
1997
421
0.010
Why?
Mass Screening
1
2001
979
0.010
Why?
HeLa Cells
1
1996
563
0.010
Why?
Adult
2
2009
30375
0.010
Why?
Surveys and Questionnaires
1
2006
4595
0.010
Why?
Epidermal Growth Factor
1
1994
160
0.010
Why?
Calcimycin
1
1994
47
0.010
Why?
Prognosis
1
2001
3315
0.010
Why?
Interferon-beta
1
1994
79
0.010
Why?
Neoplasm Staging
1
1997
1162
0.010
Why?
Mice, Inbred C3H
1
1994
242
0.010
Why?
Cell Survival
1
1996
1014
0.010
Why?
Macrophage Activation
1
1994
163
0.010
Why?
Analysis of Variance
1
1993
1218
0.010
Why?
Interferon-gamma
1
1994
719
0.010
Why?
Mutation
1
2000
3338
0.010
Why?
Peptides
1
1994
847
0.010
Why?
Tumor Necrosis Factor-alpha
1
1994
1128
0.000
Why?
Retrospective Studies
1
2005
12521
0.000
Why?
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)